Health Canada
Symbol of the Government of Canada

Institutional links

Drugs and Health Products

Globe Artichoke

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

Note: The archived version of this monograph has been temporarily removed. For an electronic copy of this archived version, please contact the Natural Health Products Directorate (NHPD) at NHPD_DPSN@hc-sc.gc.ca.


Date: April 10, 2008

Proper name(s): Cynara cardunculus L., synonym: Cynara scolymus L. (Asteraceae) (USDA 2007)

Common name(s): Globe artichoke, artichoke, cynara (McGuffin et al. 2000)

Source material(s): Leaf (Bradley 2006; ESCOP 2003; Blumenthal et al. 2000)

Route(s) of administration: Oral

Dosage form(s): Those suited to the allowable route(s) of administration.
This monograph is not intended to include food-like dosage forms such as bars, chewing gums or beverages.

Use(s) or Purpose(s): Statement(s) to the effect of:

  • Used in Herbal Medicine to help relieve digestive disturbances, such as dyspepsia (Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).
  • Used in Herbal Medicine to help increase bile flow (choleretic)

(Bradley 2006; Mills and Bone 2005; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

Dose(s): Preparations equivalent to 1.5-10 g dried leaf, per day (Bradley 2006; Mills and Bone 2005; ESCOP 2003; Blumenthal et al. 2000).

See Appendix 1 for examples of appropriate dosage preparations and frequencies of use, according to cited references. The purpose of Appendix 1 is to provide guidance to industry.

Duration of use: No statement required.

Risk information: Statement(s) to the effect of:

Caution(s) and warning(s):

  • Consult a health care practitioner if symptoms persist or worsen.
  • Consult a health care practitioner prior to use if you are pregnant (Barnes et al. 2007; Mills and Bone 2005; ESCOP 2003).
  • Consult a health care practitioner prior to use if you have gall stones (Mills and Bone 2005; ESCOP 2003; Brinker 2001; Blumenthal et al. 2000)

Contraindication(s):

  • Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family (Brinker 2008; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).
  • Do not use if you have a bile duct obstruction (Brinker 2008; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).

Known adverse reaction(s): Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use (Brinker 2008; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).

Non-medicinal ingredients: Must be chosen from the current NHPD List of Acceptable Non-medicinal Ingredients and must meet the limitations outlined in the list.

Specifications:

  • The finished product must comply with the minimum specifications outlined in the current NHPD Compendium of Monographs.
  • The medicinal ingredient may comply with the specifications outlined in the Artichoke Leaf Monograph published in the British Pharmacopoeia.

References cited:

Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.

Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.

Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.

Brinker F. Online Updates and Additions to Herb Contraindications and Drug Interactions, 3rd edition. Sandy (OR): Eclectic Medical Publications; 2008. [Accessed 2008-04-10]. Available from: http://www.eclecticherb.com/emp/updatesHCDI.html

Brinker F. Herb Contraindications and Drug Interactions, 3rd edition. Sandy (OR): Eclectic Medical Publications; 2001.

ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.

McGuffin M, Kartesz JT, Leung AY, Tucker AO, editors. Herbs of Commerce, 2nd edition. Silver Spring (MD): American Herbal Products Association; 2000.

Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

USDA 2007: ARS, National Genetic Resources Program. Germplasm Resources Information Network (GRIN). Cynara cardunculus L. National Germplasm Resources Laboratory, Beltsville (MD). [Accessed 2008-04-10]. Available from: http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl

References reviewed:

Sinayoko L, Mennecier D, El Jahir Y, Corberand D, Harnois F, Thiolet C, Farret O. [Acute hepatic injury secondary to ingestion of artichoke extracts (Hepanephrol).] Atteinte hépatique aiguë secondaire à la prise d'extraits d'artichaut (Hépanéphrol®). Gastroentérologie clinique et biologique 2007; 31(11):1039-1040 (in French).

Appendix 1: Examples of appropriate dosage preparations and frequencies of use

Dried leaf: 6 g, per day (Blumenthal et al. 2000)

Infusion: 5-10 g dried leaf, per day (ESCOP 2003)

Tincture: 1.5-4 g dried equivalent, per day
(1:2, 3-8 ml) (Mills and Bone 2005)

Dry aqueous extract:

  • 4.5-9 g dried equivalent, per day (Bradley 2006)
  • 5-10 g dried equivalent, per day (ESCOP 2003)